Repligen Statistics
Total Valuation
Repligen has a market cap or net worth of $7.49 billion. The enterprise value is $7.42 billion.
Important Dates
The next estimated earnings date is Wednesday, April 30, 2025, before market open.
Earnings Date | Apr 30, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Repligen has 56.15 million shares outstanding. The number of shares has decreased by -0.78% in one year.
Current Share Class | 56.15M |
Shares Outstanding | 56.15M |
Shares Change (YoY) | -0.78% |
Shares Change (QoQ) | +0.08% |
Owned by Insiders (%) | 0.48% |
Owned by Institutions (%) | 101.52% |
Float | 52.52M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 77.97 |
PS Ratio | 11.76 |
Forward PS | 10.54 |
PB Ratio | 3.79 |
P/TBV Ratio | 13.77 |
P/FCF Ratio | 50.03 |
P/OCF Ratio | 42.71 |
PEG Ratio | 2.24 |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 87.39, with an EV/FCF ratio of 49.56.
EV / Earnings | n/a |
EV / Sales | 11.69 |
EV / EBITDA | 87.39 |
EV / EBIT | 486.66 |
EV / FCF | 49.56 |
Financial Position
The company has a current ratio of 8.41, with a Debt / Equity ratio of 0.35.
Current Ratio | 8.41 |
Quick Ratio | 7.03 |
Debt / Equity | 0.35 |
Debt / EBITDA | 6.04 |
Debt / FCF | 4.58 |
Interest Coverage | 0.68 |
Financial Efficiency
Return on equity (ROE) is -1.30% and return on invested capital (ROIC) is 0.36%.
Return on Equity (ROE) | -1.30% |
Return on Assets (ROA) | 0.34% |
Return on Invested Capital (ROIC) | 0.36% |
Return on Capital Employed (ROCE) | 0.56% |
Revenue Per Employee | $356,827 |
Profits Per Employee | -$14,350 |
Employee Count | 1,778 |
Asset Turnover | 0.22 |
Inventory Turnover | 1.83 |
Taxes
Income Tax | -1.52M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.79% in the last 52 weeks. The beta is 0.95, so Repligen's price volatility has been similar to the market average.
Beta (5Y) | 0.95 |
52-Week Price Change | -27.79% |
50-Day Moving Average | 154.53 |
200-Day Moving Average | 145.59 |
Relative Strength Index (RSI) | 37.13 |
Average Volume (20 Days) | 716,794 |
Short Selling Information
The latest short interest is 3.80 million, so 6.76% of the outstanding shares have been sold short.
Short Interest | 3.80M |
Short Previous Month | 3.45M |
Short % of Shares Out | 6.76% |
Short % of Float | 7.23% |
Short Ratio (days to cover) | 4.89 |
Income Statement
In the last 12 months, Repligen had revenue of $634.44 million and -$25.51 million in losses. Loss per share was -$0.46.
Revenue | 634.44M |
Gross Profit | 318.67M |
Operating Income | 15.25M |
Pretax Income | 10.18M |
Net Income | -25.51M |
EBITDA | 84.90M |
EBIT | 15.25M |
Loss Per Share | -$0.46 |
Full Income Statement Balance Sheet
The company has $757.36 million in cash and $686.25 million in debt, giving a net cash position of $71.11 million or $1.27 per share.
Cash & Cash Equivalents | 757.36M |
Total Debt | 686.25M |
Net Cash | 71.11M |
Net Cash Per Share | $1.27 |
Equity (Book Value) | 1.97B |
Book Value Per Share | 35.17 |
Working Capital | 939.25M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $175.39 million and capital expenditures -$25.68 million, giving a free cash flow of $149.72 million.
Operating Cash Flow | 175.39M |
Capital Expenditures | -25.68M |
Free Cash Flow | 149.72M |
FCF Per Share | $2.67 |
Full Cash Flow Statement Margins
Gross margin is 50.23%, with operating and profit margins of 2.40% and -4.02%.
Gross Margin | 50.23% |
Operating Margin | 2.40% |
Pretax Margin | -4.26% |
Profit Margin | -4.02% |
EBITDA Margin | 13.38% |
EBIT Margin | 2.40% |
FCF Margin | 23.60% |
Dividends & Yields
Repligen does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.78% |
Shareholder Yield | 0.78% |
Earnings Yield | -0.34% |
FCF Yield | 2.00% |
Dividend Details Analyst Forecast
The average price target for Repligen is $177.78, which is 33.26% higher than the current price. The consensus rating is "Buy".
Price Target | $177.78 |
Price Target Difference | 33.26% |
Analyst Consensus | Buy |
Analyst Count | 12 |
Revenue Growth Forecast (5Y) | 15.97% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Repligen has an Altman Z-Score of 7.03 and a Piotroski F-Score of 5.
Altman Z-Score | 7.03 |
Piotroski F-Score | 5 |